DPP-IV inhibitor anagliptin exerts anti-inflammatory effects on macrophages, adipocytes, and mouse livers by suppressing NF-κB activation (Q38870486)

7 September 2017

DPP-IV inhibitor anagliptin exerts anti-inflammatory effects on macrophages, adipocytes, and mouse livers by suppressing NF-κB activation (English)

1 reference

7 September 2017

0 references

7

1 reference

7 September 2017

Takanori Shinjo

1

1 reference

7 September 2017

Yusuke Nakatsu

2

1 reference

7 September 2017

Misaki Iwashita

3

1 reference

7 September 2017

Tomomi Sano

4

1 reference

7 September 2017

Hideyuki Sakoda

5

1 reference

7 September 2017

Hisamitsu Ishihara

6

1 reference

7 September 2017

Midori Fujishiro

8

1 reference

7 September 2017

Toshiaki Fukushima

9

1 reference

7 September 2017

Yoshihiro Tsuchiya

10

1 reference

7 September 2017

Hideaki Kamata

11

1 reference

7 September 2017

Fusanori Nishimura

12

1 reference

7 September 2017

Tomoichiro Asano

13

1 reference

7 September 2017

26 May 2015

1 reference

American Journal of Physiology - Endocrinology and Metabolism

7 September 2017

1 reference

7 September 2017

309

1 reference

7 September 2017

3

1 reference

7 September 2017

E214-23

1 reference

Early B-cell factor (O/E-1) is a promoter of adipogenesis and involved in control of genes important for terminal adipocyte differentiation.

7 September 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

The C type natriuretic peptide receptor tethers AHNAK1 at the plasma membrane to potentiate arachidonic acid-induced calcium mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Tumor necrosis factor receptor-associated factors (TRAFs)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

A phosphotyrosine-dependent protein interaction screen reveals a role for phosphorylation of caveolin-1 on tyrosine 14: recruitment of C-terminal Src kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Glucagon-like peptide 1 reduces endothelial dysfunction, inflammation, and oxidative stress induced by both hyperglycemia and hypoglycemia in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Beneficial effect of a CXCR4 agonist in murine models of systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Caveolin-1 associates with TRAF2 to form a complex that is recruited to tumor necrosis factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Role of interleukins in obesity: implications for metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Structure and function in dipeptidyl peptidase IV and related proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Stress-induced decrease in TRAF2 stability is mediated by Siah2

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Dipeptidyl peptidase IV (DP IV, CD26) in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Inflammation and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Valsartan, independently of AT1 receptor or PPARγ, suppresses LPS-induced macrophage activation and improves insulin resistance in cocultured adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Interrelationship of dipeptidyl peptidase IV (DPP4) with the development of diabetes, dyslipidaemia and nephropathy: a streptozotocin-induced model using wild-type and DPP4-deficient rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Recent advances in our understanding of insulin action and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Characterization of Tollip protein upon Lipopolysaccharide challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Peptidomics of the prolyl peptidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Adipose tissue macrophages: MR tracking to monitor obesity-associated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Dipeptidyl peptidase-4 inhibitor, sitagliptin, improves endothelial dysfunction in association with its anti-inflammatory effects in patients with coronary artery disease and uncontrolled diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Toll-like receptors and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Prevention of obesity-induced renal injury in male mice by DPP4 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

CD26 mediates dissociation of Tollip and IRAK-1 from caveolin-1 and induces upregulation of CD86 on antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

CD26 up-regulates expression of CD86 on antigen-presenting cells by means of caveolin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Macrophages, inflammation, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Signaling pathways in insulin action: molecular targets of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

A novel splice variant of interleukin-1 receptor (IL-1R)-associated kinase 1 plays a negative regulatory role in Toll/IL-1R-induced inflammatory signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

DP IV/CD26, APN/CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Highlights of 10 years of immunology in Nature Reviews Immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

AMPK regulates macrophage polarization in adipose tissue inflammation and NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Glucagon-like peptide-1 receptor agonists for diabetes mellitus: a role in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Obesity is associated with macrophage accumulation in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Macrophage-adipocyte interaction: marked interleukin-6 production by lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Deficiency in adipocyte chemokine receptor CXCR4 exacerbates obesity and compromises thermoregulatory responses of brown adipose tissue in a mouse model of diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

Negative regulation of toll-like receptor-mediated signaling by Tollip

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: potential implications in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00553.2014

10.1152/AJPENDO.00553.2014

21 January 2018

Identifiers

DOI

1 reference

7 September 2017

1 reference